University Hospital, Montpellier: Cystic Fibrosis trials

The registry lists 17 Cystic Fibrosis studies with University Hospital, Montpellier as lead sponsor. 1 are open to participants now and 0 have results posted.

Early Phase 1 1No phase 16(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic FibrosisRecruitingNCT06602869
• Cardiopulmonary Fitness in Children With Cystic Fibrosis Compared to Healthy ChildrenCompletedNCT06242951
• Validation of Therapeutic Efficacy Targeting the Splicing Variants in Cystic Fibrosis and CFTR PathologiesTerminatedNCT05100823Not applicable
• Characterization of Pulmonary Microbiome in Cystic Fibrosis PatientsStatus unknownNCT04735679
• Anti-IL5 and Other Biotherapies in Cystic FibrosisStatus unknownNCT04256772
• Educational Program Through Video Conference for Inhaled Therapies in Cystic Fibrosis PatientsCompletedNCT03850145
• In Vitro Model of the Cystic Fibrosis Bronchial Epithelium Via iPS TechnologyCompletedNCT03754088
• Small Circulating RNA as Molecular Markers of Lung Disease in Cystic FibrosisCompletedNCT02992080Not applicable
• Identification of Predictive Epigenetic Biomarkers of Lung Disease Severity in Cystic FibrosisCompletedNCT02976714Not applicable
• DNA Methylation and Lung Disease in Cystic FibrosisCompletedNCT02884622Not applicable
• Early Assessment of Respiratory Function, Inflammation and Bronchial Reshuffle Among Newborns Screened for Cystic FibrosisCompletedNCT02883816Not applicable
• Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis PatientsTerminatedNCT02550041Not applicable
• Respiratory Function at Preschool Age of Children Detected of Cystic Fibrosis in Neonatal PeriodCompletedNCT02358798Not applicable
• Non Ivasive Prenatal Diagnosis (NIPD) of Cystic FibrosisStatus unknownNCT02130648
• Muco Smartphone ExacerbationCompletedNCT02122289Early Phase 1
• Action of Epigenetic Modifiers in Cystic Fibrosis TreatmentCompletedNCT01883284Not applicable
• Bacteriophage Effects on Pseudomonas AeruginosaCompletedNCT01818206Not applicable